Back to Results

Watchman for patients with atrial fibrillation undergoing transcatheter aortic valve replacement

Study category: Heart and Blood Conditions

Is this Study for You?

Let's Get Started!

Description

WATCH-TAVR is a prospective, multicenter, randomized event-driven controlled trial.

Details
Age

Adult

Eligibility

- Patient meets criteria for and is eligible to undergo TAVR procedure - Patient meets the WATCHMAN labeling guidelines and is eligible to undergo the WATCHMAN implantation procedure.

Phase

Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.

Type of Study

Treatment

Locations

Harmony Campus
Medical Center of the Rockies

Principal Investigator
Justin Strote

Justin Strote

Study ID

Protocol Number: 18-6002

ClinicalTrials.gov: NCT03173534

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers